Articles published by Ardelyx, Inc.
Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference
September 05, 2024
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
August 08, 2024
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Ardelyx, Inc. Reports Employment Inducement Grants
May 30, 2024
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
May 16, 2024
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Ardelyx, Inc. Reports Employment Inducement Grants
May 14, 2024
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Ardelyx, Inc. Reports Employment Inducement Grants
March 28, 2024
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Ardelyx, Inc. Reports Employment Inducement Grants
March 12, 2024
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Ardelyx to Participate at the Cowen 44th Annual Health Care Conference
February 27, 2024
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 22, 2024
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
February 01, 2024
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Ardelyx, Inc. Reports Employment Inducement Grants
January 12, 2024
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities
January 08, 2024
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Ardelyx to Provide Company Update on IBSRELA® and Host a KOL Discussion on the IBS-C Landscape on Monday, January 8
January 03, 2024
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Ardelyx, Inc. Reports Employment Inducement Grants
December 20, 2023
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Ardelyx, Inc. Reports Employment Inducement Grants
November 21, 2023
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia
November 15, 2023
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free